PharmacometricsAI

AI platform focused on sharing and building tools brick by brick for analysts to tackle all aspects of pharmacometrics.

[PharmacometricsAI @PharmaAI1]

ML-enabled PK/PD review
Psarellis et al. group ML/AI in PK/PD into parameter prediction and time-course forecasting. They highlight gray-box models combining ML + mechanistic structure for better prediction, variability handling, and NAM-aligned decisions.
https://t.co/vPXKbNTN5B

[PharmacometricsAI @PharmaAI1]

🌟 Featured Article: QSP-Copilot by Anuraag Saini & Ali Farnoud uses AI agents to extract knowledge from literature and build QSP models. With up to ~40% faster development, it accelerates QSP research.
Link https://t.co/8f3FhrSJn8
App https://t.co/p7ihRs4fKH

[PharmacometricsAI @PharmaAI1]

🌟 Featured Article: Danniell Hu, “Human at the Center” reframes AI beyond speed/accuracy via 3 pillars (design, user testing, ethics) + 4 human–AI modes.
In pharmacometrics: from RMSE-driven modeling → human-centered decisions in drug development.
https://t.co/95VXfDctVE

[PharmacometricsAI @PharmaAI1]

From automating coding in pharmacometrics and complex data management to generating clinical reports with good context retention, see top models - like Claude 4.6, GPT-5.5, and Gemini 3.1 Pro that are currently dominating each stage of the pharmacometrics workflow...

[PharmacometricsAI @PharmaAI1]

🌟 Featured article: by Ahmad, Ouahada, and Hamam on AI/ML for drug target interaction predictions.

The key question is ...can computers predict which drugs will "stick to" which proteins, before doing expensive experiments/studies?

#pharma #pharmacometrics #clinical #clinpharm

[PharmacometricsAI @PharmaAI1]

🌟 Featured article: A commentary on AI Approach to generating MIDD assets...

This 2023 article sheds some light on how AI/ML is revolutionizing Model-Informed Drug Development.

Ref: https://t.co/TYLYPnEvD7

[PharmacometricsAI @PharmaAI1]

🌟 Featured Article: Evaluating the Impact of AI-Based Model-Informed Drug Development

Here's a comparative review by Bingyu Mao et al that delivers an electrifying systematic analysis of how AI/ML is revolutionizing MIDD!

https://t.co/ULPb30JzwR

[PharmacometricsAI @PharmaAI1]

🎙️ Let us know if you would like to share something related to AI in Pharmacometrics
#pharmacometrics #ai #Clinicaltrial

[PharmacometricsAI @PharmaAI1]

🌟 Introducing our official site. Take a look at our solutions! https://t.co/w9YHXdWe3i